Figure 3From: PCA3 in prostate cancer and tumor aggressiveness detection on 407 high-risk patients: a National Cancer Institute experience ROC analysis with evaluation of the corresponding AUC for tPSA (0.505), f/tPSA (0.607) and PCA3 score (0.865). Back to article page